Funded Startups in Farmingdale
Six funded rounds are listed for Farmingdale, spanning 2022-10-17 (TiniFiber, undisclosed) to 2025-11-02 (Chirality Biosciences, Seed, $3M).
Six funded rounds are listed for Farmingdale, spanning 2022-10-17 (TiniFiber, undisclosed) to 2025-11-02 (Chirality Biosciences, Seed, $3M). Disclosed amounts are concentrated at the low end: Chirality Biosciences’ $3M is the largest disclosed round, and it dwarfs the next-largest disclosed amount of $6M? (No, Codagenix shows $6M on 2023-10-24; therefore $6M is the largest disclosed amount, and it dwarfs $3M and the rest.) The biggest disclosed round is Codagenix ($6M) dated 2023-10-24, while the smallest disclosed amount is VectorMAX at $10K (2025-05-14), creating a wide spread between biotech-heavy outcomes and much smaller hardware funding. Two date clusters stand out within the dataset: three entries are dated 2023-10-24 (Codagenix $6M, Precipart undisclosed, and no other 2023-10-24 besides those two; and Codagenix/Precipart share that date), and multiple rounds occur in 2025 (VectorMAX 2025-05-14 at $10K, Chirality Biosciences 2025-11-02 at $3M, and Podbul 2025-01-14 at $300K). Sector coverage is led by biotechnology/pharma: Biotechnology appears in Chirality Biosciences (2025-11-02, $3M) and Codagenix (2023-10-24, $6M), with additional entries in Health Care (Precipart, 2023-10-24, undisclosed) and other non-biotech verticals (Hardware, Clothing and Apparel, Manufacturing). Stage labels are incomplete: 2/6 are “undisclosed” by amount (Precipart; TiniFiber), and 3/6 are marked “Series Unknown” (VectorMAX, Codagenix, Precipart).
Most recent rounds
6 shownRelated listings
Frequently asked
What is the largest disclosed round in the Farmingdale list, and how uneven are the disclosed amounts compared with the rest?
Codagenix’ $6M round on 2023-10-24 is the largest disclosed amount in these rows, and it sits far above the next-largest disclosed amount of $3M (Chirality Biosciences on 2025-11-02). The smallest disclosed amount is VectorMAX at $10K (2025-05-14), making the disclosed range much wider than the mid-tier rounds like Podbul’s $300K (2025-01-14).
Are there noticeable temporal clusters in the most recent Farmingdale entries shown here?
The dataset spans 2022-10-17 to 2025-11-02, with two 2025 rounds in the first half of the year (Podbul on 2025-01-14 at $300K and VectorMAX on 2025-05-14 at $10K) and a later biotech/Seed datapoint on 2025-11-02 (Chirality Biosciences at $3M). Additionally, two entries share the exact same round date, 2023-10-24 (Codagenix and Precipart).
Which sectors appear most often, and does that concentration line up with the largest disclosed amount?
Biotechnology appears in two of the six rows: Chirality Biosciences (2025-11-02, Seed, $3M) and Codagenix (2023-10-24, Series Unknown, $6M). The largest disclosed round ($6M) is therefore tied to biotechnology, while other sectors in the list (Hardware, Clothing and Apparel, Health Care, Manufacturing) show up only once each.
What stage labeling patterns show up, and how many entries can’t be assessed by disclosed amount?
Stage classifications are frequently incomplete: 3 of 6 rows are labeled “Series Unknown” (VectorMAX on 2025-05-14 for $10K; Codagenix on 2023-10-24 for $6M; Precipart on 2023-10-24 with an undisclosed amount). Independently of stage, 2 of 6 rows have “undisclosed” amounts (Precipart; TiniFiber), which prevents comparing those rounds in size alongside disclosed amounts like $3M and $300K.
Which entry looks like an outlier in disclosed size, even within a single city?
VectorMAX’ $10K round on 2025-05-14 is an outlier on the low end versus the rest of the disclosed amounts ($300K for Podbul on 2025-01-14, $3M for Chirality Biosciences on 2025-11-02, and $6M for Codagenix on 2023-10-24). On the high end, Codagenix’ $6M on 2023-10-24 is the standout disclosed amount in this set.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.